ASTRAZENECA PLC - 31 Mar 2025 SCHEDULE 13G/A Report for Conduit Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (CDT)

Filing Manager: ASTRAZENECA PLC
Reporting Manager: AstraZeneca PLC
Security: Conduit Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Symbol: CDT
Shares outstanding: 6.72M shares
Disclosed Ownership: 73.9K shares
Ownership: 1.1%
Form type: SCHEDULE 13G/A
Filing time: 10 Apr 2025, 06:00:23 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
AstraZeneca PLC	1.1%	73.9K	73.9K	0	/s/ Adrian Kemp	Adrian Kemp, Company Secretary
AstraZeneca AB	1.1%	73.9K	73.9K	0	/s/ Lars-Johan Cederbrant	Lars-Johan Cederbrant, Director and CFO